Financials & Reports
Explore key financial metrics, condensed statements and narrative analysis from Laurel Ridge Health’s FY 2024 Annual Financial Report. The data below (rounded to the nearest thousand dollars) provides a starting point for deeper case exercises.
Financial highlights
These metrics highlight a system under some financial strain—particularly in liquidity—but still generating positive margins supported by non‑operating income. Use them as benchmarks to explore how changes in payer mix, expenses or investment returns would affect performance.
Condensed balance sheet
The balance sheet (or statement of financial position) summarizes assets, liabilities and net assets at year end. Laurel Ridge saw significant growth in its asset base in FY 2024, financed primarily through increased long‑term debt.
| Assets | FY2024 ($000s) | FY2023 ($000s) |
|---|---|---|
| Cash & Cash Equivalents | 122,140 | 110,000 |
| Short‑term Investments | 48,000 | 53,000 |
| Net Patient Accounts Receivable | 147,000 | 112,000 |
| Inventories | 21,250 | 16,500 |
| Total Current Assets | 338,390 | 291,500 |
| Long‑term Investments | 225,000 | 190,000 |
| Net Property & Equipment | 457,000 | 380,000 |
| Total Assets | 1,020,390 | 861,500 |
| Liabilities & Net Assets | FY2024 ($000s) | FY2023 ($000s) |
|---|---|---|
| Accounts Payable | 117,000 | 97,000 |
| Accrued Expenses | 72,000 | 62,000 |
| Notes Payable (Current) | 38,500 | 32,500 |
| Total Current Liabilities | 227,500 | 191,500 |
| Long‑term Debt | 415,000 | 325,000 |
| Total Liabilities | 642,500 | 516,500 |
| Net Assets | 377,890 | 345,000 |
| Total Liabilities & Net Assets | 1,020,390 | 861,500 |
Assets grew 18% in FY 2024 due to capital additions and investment growth. Long‑term debt increased significantly to fund expansion projects, pushing the leverage ratio higher. Net assets increased modestly, reflecting retained earnings from net income and contributions.
Condensed statement of operations
The statement of operations (income statement) summarizes revenues and expenses during the fiscal year. It reveals whether Laurel Ridge generated a surplus from operations and how non‑operating items affect the bottom line.
| Operating Results | FY2024 ($000s) | FY2023 ($000s) |
|---|---|---|
| Net Patient Service Revenue | 651,000 | 615,000 |
| Premium Revenue | 76,000 | 74,000 |
| Other Revenue | 67,000 | 39,000 |
| Total Operating Revenue | 794,000 | 728,000 |
| Salaries, Wages & Benefits | 428,000 | 383,000 |
| Supplies & Drugs | 198,000 | 172,000 |
| Purchased Services & Other | 115,000 | 109,400 |
| Depreciation & Amortization | 28,000 | 22,000 |
| Interest Expense | 18,000 | 16,000 |
| Total Operating Expenses | 787,000 | 702,400 |
| Operating Income | 7,000 | 25,600 |
| Non‑Operating Contributions & Investment Income | 25,490 | 26,980 |
| Net Income (Excess Revenue over Expenses) | 32,490 | 52,580 |
Operating revenue grew 9% in FY 2024 but expenses rose 12%, compressing the operating margin to 0.9% on a full accrual basis. A strong investment portfolio and modest contributions lifted the overall net margin to 4.1% (rounded), though still slightly below peer medians. Note how the mix of revenues (patient, premium, other) and the cost structure drive operating results.
Condensed statement of cash flows
Cash flow information illuminates how Laurel Ridge funds its operations, investments and financing activities. The summary below highlights major cash inflows and outflows during FY 2024.
| Cash Flows | FY2024 ($000s) |
|---|---|
| Net Cash from Operating Activities | 25,250 |
| Net Cash Used in Investing Activities | (109,760) |
| Net Cash from Financing Activities | 96,650 |
| Net Increase in Cash & Equivalents | 12,140 |
Operating activities generated positive cash despite reduced net income, reflecting depreciation and working capital adjustments. Significant capital expenditures and investment purchases drove negative investing cash flow, while debt issuance and a bank loan provided strong financing inflows. The result was a modest increase in cash of $12.14 million, keeping liquidity stable.
Narrative & analysis
The FY 2024 financials present a nuanced picture of a growing nonprofit health system balancing mission and margin. Revenue increases were offset by wage inflation, supply costs and interest expense, compressing the operating margin. Investment gains and donations remain crucial to achieving a positive bottom line. The system’s leverage has increased to fund expansion, evidenced by a higher debt‑to‑equity ratio and more long‑term debt on the balance sheet. Days cash on hand improved modestly but remains below industry medians, highlighting the importance of disciplined liquidity management.
Use this information as a springboard for analysis. What happens if payer mix shifts further toward Medicaid? How would a downturn in investment markets affect net income and liquidity? How much debt capacity remains for future projects? These questions and more are explored throughout the Laurel Ridge case.
For the full audited statements, notes and supplemental graphs, download the FY 2024 Annual Financial Report included with the case materials.